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E-mail address: cyytoyo@mail.ecc.u-tokyo.ac.jp (YCytoplasmic dynein is a microtubule (MT) motor protein comprising two classes: dynein-1 and
dynein-2. We puriﬁed recombinant human dynein-1 and dynein-2 from HEK-293 cells by expressing
the streptavidin-binding peptide-tagged human cytoplasmic dynein-1 and dynein-2 heavy chains
(HCs), respectively. Electron microscopy of the puriﬁed molecules revealed a two-headed structure
composed of characteristic dynein motor domains. In an in vitro MT gliding assay, both dynein-1
and dynein-2 showed minus-end-directed motor activities. This is the ﬁrst demonstration of
dynein-2 motor activity, which supports the retrograde intraﬂagellar transport role of dynein-2.
Our expression system of dynein HCs provides a useful means to investigate dynein functions.
Structured summary of protein interactions:
DYNC1H1 (Homo sapiens) binds toDYNC1H1 (Homo sapiens) by electronmicroscopy (View interaction)
DYNC1H1 (Sus scrofa) binds toDYNC1H1 (Sus scrofa) by electronmicroscopy (View interaction)
DYNC2H1 (Homo sapiens) binds toDYNC2H1 (Homo sapiens) by electron microscopy (View interaction)
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Cytoplasmic dynein is a microtubule (MT) motor protein that is
involved in various activities within eukaryotic cells. Cytoplasmic
dynein comprises two classes: dynein-1 and dynein-2 [1]. Cyto-
plasmic dynein-1 is a minus-end-directed MT motor protein that
moves by the energy derived from ATP hydrolysis [2], and is in-
volved in cell division, cargo transport, and neural development
[3,4]. The structure of dynein-1 and its motile properties have
gradually been ascertained via electron microscopy, recombinant
protein expression, motility assays, and X-ray crystallography [5–
8]. In contrast, cytoplasmic dynein-2 is reported to be involved in
intraﬂagellar transport (IFT), which is a bidirectional transport of
particles along axonemes in cilia and ﬂagella. Dynein-2 is a puta-
tive retrograde IFT motor, which transports IFT particles from the
ciliary tip toward the cell body [9]. Recent studies have shown that
deﬁcits of dynein-2 heavy chain (HC) cause some human ciliopa-
thies [10]. However, the molecular structure and motile properties
of cytoplasmic dynein-2 are yet to be elucidated. In previous stud-
ies, the information on dynein-2 motility was limited to in situchemical Societies. Published by E
reptavidin-binding peptide
.Y. Toyoshima).data obtained from Chlamydomonas and Caenorhabditis elegans
[11,12].
To date, the expression system of functional cytoplasmic dynein
HC has been limited to lower eukaryotes such as Dictyostelium and
yeast [6,7]. In this report, we puriﬁed recombinant human cyto-
plasmic dynein-1 and dynein-2 from HEK-293 cells by expressing
the streptavidin-binding peptide (SBP)-tagged human cytoplasmic
dynein-1 HC (DYNC1H1, 530 kDa) and cytoplasmic dynein-2 HC
(DYNC2H1, 490 kDa). Electron microscopy (EM) showed that
both puriﬁed dynein-1 and dynein-2 molecules had a two-headed
structure composed of two motor domains. Both puriﬁed dynein-1
and dynein-2 possessed the minus-end-directed motor activities as
demonstrated by an in vitro MT gliding assay. This is the ﬁrst
report to describe the structure and motility of dynein-2 in vitro.
2. Materials and methods
2.1. Generation of cDNA construct and transfection
Full lengths of DYNC1H1 cDNA or DYNC2H1 cDNA were in-
serted into pcDNA5/FRT/TO vector (Invitrogen). SBP-tag (for puriﬁ-
cation) and SNAP-tag (for analysis) were inserted at N-termini of
both DYNC1H1 and DYNC2H1 (further details are provided in the
Supplementary methods).lsevier B.V. All rights reserved.
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ium (Invitrogen) supplemented with 10% fetal calf serum and
2 mM L-glutamine. To generate the SBP–SNAP–dynein-1 HC and
SBP–SNAP–dynein-2 HC stable cell lines, the vectors were transfec-
ted into the HEK-293 cells using a Lipofectamine reagent and Plus
reagent (Invitrogen) according to manufacturer’s instructions. The
transfectants were screened by hygromycin (100 lg/ml) resistance
and Western blots targeting the SNAP-tag.
2.2. Preparation of proteins
After inducing protein expression with 2 lg/ml doxycycline, the
HEK-293 cells expressing the recombinant dynein-1 HC or recom-
binant dynein-2 HC were homogenized and centrifuged in buffer A
(50 mM Tris–HCl, pH 7.5, 0.2 M NaCl, 10% sucrose, 5 mM MgSO4,
0.1 mM ATP, 1 mM DTT) containing 0.05% Triton X-100 and
complete mini protease inhibitor cocktail (Roche). The lysates were
applied to a StrepTrap HP column (GE Healthcare) or a Streptactin-
column (IBA) pre-equilibrated with buffer A. The bound proteins
were eluted with buffer A containing 2.5 mM desthiobiotin.
Porcine brain dynein-1 and tubulin was prepared as described
in [13].
2.3. SDS–PAGE, Western blotting
The proteins were separated by SDS–PAGE with 10% polyacryl-
amide gels, and stained with Coomassie brilliant blue (CBB). For
Western blotting, the separated proteins were transferred onto
polyvinylidene ﬂuoride (PVDF) membranes using standard tech-2 tail domain
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Fig. 1. (a) A schematic diagram of the constructs used in this study. (b) SDS–PAGE of puri
dynein-2 with the indicated antibodies, showing no cross-contamination between the tniques. Polyclonal antibodies against SNAP-tag (GenScript,
A00684) and DYNC2H1 (a kind gift from Dr. Kazuo Ogawa, NIBB)
were both used at a dilution of 1:1000. The polyclonal IC74 (Ab-
cam, ab6304) antibody was used at a 1:2000 dilution and the poly-
clonal LIC3 (ProteinTech, 15949-1-AP) antibody was diluted 1:500.
Positive bands were detected using a BCIP/NBT system (KPL).
2.4. Electron microscopy
The puriﬁed proteins (15–30 lg/ml) were applied to carbon
grids pre-hydrophilized as described elsewhere [14] and
negatively stained with 1.5% uranyl acetate. The specimens
were examined in an H-7500 electron microscope (Hitachi) at
15 000 or 40 000magniﬁcation operating at 80 kV. The distance
between dynein motor domains was measured using ImageJ
software (NIH).
2.5. In vitro MT gliding assay
The in vitro MT gliding assay was observed under a dark-ﬁeld
microscope and analyzed basically as described elsewhere [15].
The motility assay for dynein-1 was carried out in buffer B
(10 mM PIPES–KOH, 4 mM MgSO4, 1 mM EGTA, 1 mM DTT,
10 lM paclitaxel, 1 mM ATP, pH 7.0) containing 50 mM K-acetate.
The motility assay for dynein-2 was carried out in buffer B without
K-acetate. The MTs that moved continuously at least 2 lm were
analyzed to measure gliding velocity.
Polarity marked MTs were prepared as described previously
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Fig. 2. (a) The EM images of the puriﬁed recombinant dynein-1 molecules and
native porcine brain dynein-1. Scale bars, 50 nm. (b) The EM images of the puriﬁed
recombinant dynein-2 molecules. Pairs of two dynein motor domains were
observed. Red arrowheads indicate the thin tail structures. Scale bars, 50 nm. (c)
Schematic diagrams of the dynein-1 and dynein-2 complexes, which were adapted
from Ref. [1].
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3.1. Properties of the recombinant cytoplasmic dynein-1
In this study, SBP-tagged and SNAP-tagged recombinant human
cytoplasmic dynein-1 HC and dynein-2 HC molecules were con-
structed (Fig. 1a), and transfected into HEK-293 cells. First, we
puriﬁed the recombinant dynein-1 from the HEK-293 cells. Using
afﬁnity chromatography a yield of 83.6 lg of the recombinant
dynein-1 protein (from 4  150 mm dishes, corresponding to
20.9 lg/dish) was achieved. The SDS–PAGE analysis conﬁrmed that
purity was high, and that the endogenous dynein-1 intermediate
chain (IC74) and light intermediate chains (LICs) were associated
with the recombinant dynein-1 HC (Fig. 1b). Electron microscopy
revealed that the puriﬁed dynein-1 had a structure similar to the
porcine brain dynein-1 (Fig. 2a). These results strongly suggest that
puriﬁed dynein-1 is not composed of a HC alone, but exists as a
complex with other endogenous accessory proteins.
In an in vitro MT gliding assay of puriﬁed dynein-1, robust glid-
ing of the MTs was observed in the presence of 1 mM ATP (see
Supplementary movie S1). The vast majority of MTs (97.2%, 138
out of 142) smoothly glided on the glass surface. The average veloc-
ity of the motile MTs was 905 ± 151 nm/s (mean ± S.D., n = 120)
(Fig. 3a), which was comparable with that of the porcine dynein-1
[13] and endogenous human cytoplasmic dynein-1 HC puriﬁed
withmfGFP-tagged IC74 [17]. The directionality of dynein-1-driven
MTs was determined using polarity marked MTs, and 97.8% (88 out
of 90) polarity marked MTs moved with the minus-end trailing,
which reﬂected the minus-end-directed motility of dynein-1 (see
Supplementary movie S2). The plus-end-trailing MTs (2.2%, 2 out
of 90) were thought to be improperly marked MTs due to experi-
mental limitations. Therefore, we conclude that our recombinant
dynein-1 HC is functional in vitro, and HEK-293 cells represent a
useful tool for the expression of cytoplasmic dynein HC.
3.2. Properties of the recombinant cytoplasmic dynein-2
We then puriﬁed recombinant dynein-2 from the HEK-293 cells,
and although it was of high purity (Fig. 1b), the yield was much
lower (31.0 lg from 55  150 mm dishes, corresponding to
0.564 lg/dish) than observed for dynein-1. One possible explana-
tion for this difference could be because of the negative elements
for protein expression within the dynein-2 genome sequence.
Western blots demonstrated that there was no contamination of
dynein-1 molecules in the puriﬁed dynein-2. The association of
endogenous dynein-2 light intermediate chain (DYNC2LI1/LIC3 re-
ferred to here as LIC3) to recombinant dynein-2 HC was demon-
strated via SDS–PAGE and Western blot analysis (Fig. 1b and c).
The LIC3 band was detected at around 37 kDa which was compara-
ble with the calculated size (Mr = 39 624). We could not conﬁrm
the association of the putative dynein-2 intermediate chain (IC)
(found in Chlamydomonas and zebraﬁsh [18,19], but not in hu-
mans). However, our results do not exclude the possible existence
of a human dynein-2 IC. It is possible that the dynein-2 IC dissoci-
ated from the dynein-2 complex during the preparation process.
The EM images of the puriﬁed dynein-2 showed pairs of the
characteristic dynein motor rings (Fig. 2b), reﬂecting the homodi-
meric structure of dynein-2 as previously suggested by a sedimen-
tation study [20]. Based on the assumption that either the two head
domains intimately associated (closer than 30 nmbetween centers)
with each other, or two head domains linked with a visible tail do-
main composed a dimer, 73.2% (240 out of 328) of head domains ex-
isted as a dimeric structure. The head domain of the dynein-2
molecules appeared quite similar when compared with that of dy-
nein-1. This is consistent with the fact that the head domains arewell conserved between these two dynein classes [20]. However,
the tail domain of dynein-2 was not easily visualized, and the tail
structures in some of the dynein-2molecules were barely recogniz-
able (Fig. 2b). This was in contrast with dynein-1, which was char-
acterized by a clear dense tail domain (Fig. 2a).
Fig. 3. (a) Histogram of the velocity distribution of motile MTs driven by dynein-1. (b) Histogram of the velocity distribution of motile MTs driven by dynein-2. (c) Dark-ﬁeld
images of the movement of the polarity marked MTs driven by dynein-2, showing minus-end-directed motor activity of dynein-2. Scale bar, 5 lm.
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On the glass surface coated with the puriﬁed dynein-2, some MTs
were found to move in the presence of 1 mM ATP (see Supplemen-
tary movie S3). The MT gliding by dynein-2 was not so robust as
dynein-1. For dynein-2 the number of MTs on the glass surface
and the fraction of motile MTs were much smaller than for dy-
nein-1, and the motile MTs often stopped moving. Further, the
MTs easily dissociated from the dynein-2-coated surface, and the
dissociation of MTs was much faster than observed with dynein-1.
To ascertain the optimal conditions for the dynein-2 motility as-
say, we experimented with different conditions, such as the buffer
conditions, blocking conditions of the glass surface, and the num-
ber of times of perfusion of dynein-2 solution to the glass chamber.
The MT movement was the most stable in the condition where the
dynein-2 solution (60 lg/ml) was introduced into a glass cham-
ber twice. Under this condition, 43.3% of the MTs (114 out of
263) exhibited motion, and immobile MTs were also observed
(56.7%, 149 out of 263). The average velocity of MTs that traveled
continuously at least 2 lm among the motile MTs (53 out of
114) was 69.6 ± 40.9 nm/s (mean ± S.D.) (Fig. 3b). Although the
MTs that traveled less than 2 lm or MTs changing their shapes
on the glass surface (Supplementary Fig. S1) were not included in
velocity measurement, these motion were also thought to reﬂect
dynein-2 motor activity.
Next, we used polarity marked MTs to test the directionality of
MT movement. All the polarity marked MTs that moved were with
theminus-end-trailing (n = 16) (Fig. 3c). Since the puriﬁed dynein-2
was not contaminated by dynein-1 molecules, as conﬁrmed via
Western blots (Fig. 1c) and EM observation (Fig. 2b), the minus-
end-trailing MT gliding was thought to be driven by puriﬁed
dynein-2.
From these results, we conclude that dynein-2 has motor activ-
ity and that dynein-2 is a minus-end-directed motor like other
dynein isoforms. These data strongly support the idea that
dynein-2 drives minus-end-directed retrograde IFT. This is the ﬁrst
report demonstrating dynein-2 motility in vitro.4. Discussion
4.1. The characteristics of dynein-2
The results of this study show the different structural and mo-
tile properties of dynein-1 and dynein-2. Based on the acquired EM
images, dynein-1 had a dense tail domain structure, whereas the
dynein-2 tail domain was less clear. These differences might reﬂect
the structural diversity of the dynein HCs between the two dynein
classes [20]. Another possibility is the involvement of accessory
proteins. Dynein-1 is composed of two HCs, two IC74, several light
intermediate chains (LICs), and several light chains (LC8, LC7,
Tctex1) [21]. In contrast, puriﬁed dynein-2 is thought to only be
associated with LIC3 (Fig. 2c). The molecular mass of the dynein-
1 associated proteins, particularly IC74 (74 kDa), may contribute
to its dense tail structure (Fig. 2c).
The average velocity of dynein-2-driven MTs in this study was
very slow (69.6 ± 40.9 nm/s) when compared with that of dy-
nein-1 (905 ± 151 nm/s), and even that of the retrograde IFT
in vivo (1 lm/s in C. elegans) [12]. However, very few dynein-2-
driven MTs were observed moving at higher velocities (760 nm/s,
814 nm/s, n = 1 each, Supplementary Fig. S2) that were comparable
to the velocity of the retrograde IFT. It is possible that dynein-2 has
the potential to move at this velocity, but in the motility assay uti-
lized in this study, dynein-2 was not able to achieve its maximum
potential. In this study, both dynein-1 and dynein-2 were adhered
to the glass surface non-speciﬁcally. However, as stated above, the
dynein-1 and dynein-2 tail domain structures are different and it is
possible that the tail domain of dynein-2 lead to unfavorable
attachment to the glass surface. The speciﬁc site tethering of dy-
nein-2 molecules to the glass surfaces by protein tags or antibodies
might improve the gliding assay capability of dynein-2.
In this study, we showed that the puriﬁed dynein-2 possesses
motor activity and that dynein-2 is a minus-end-directed motor
protein. These ﬁndings will facilitate new research, not just on dy-
nein-2, but also on the IFT.
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In this study, we developed a human dynein HC expression sys-
tem in HEK-293 cells. This novel system was capable of producing
recombinant HCs with motor activities for both dynein-1 and
dynein-2. It is of note that in this study the dynein HC expression
system, which in the past has been limited to lower eukaryotes,
was accomplished in mammalian cells. The expression system
described herein extends the current paradigm of dynein research,
especially with respect to mammals.
The advantage of the expression system described in this report,
and some of the possible applications are summarized as follows.
First, the full length of the human recombinant dynein-1 and
dynein-2 HCs can be puriﬁed to a very high level of purity using
a simple one-step afﬁnity chromatography process. We were able
to achieve a high yield of dynein-1, and although the yield of
dynein-2 was much lower, it was also acceptable. Secondly, the
expression system for the functional dynein HCs can be used for
molecular engineering research to study motile mechanism.
Thirdly, using this system the molecular interactions between
human dyneins and their regulatory proteins can be examined in
vitro. Finally, the system could be applied to study dynein behavior
in mammalian cells.
In conclusion, our dynein HC expression system has for the ﬁrst
time revealed the in vitro motility of dynein-2 and provides a use-
ful method to study dynein functions.
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